🔴 Rocket Pharmaceuticals is trading 5.1% down today as investors take profits after a recent biotech rally

Rocket Pharmaceuticals is trading 5.1% down at $3.71 as investors continue to take profits in the biotech sector following a strong recent rally.

• The move appears driven by broader weakness in the SPDR S&P Biotech ETF and risk-off sentiment in equity markets rather than a new company-specific catalyst.
• No fresh regulatory developments or news items were reported for the firm on July 13, 2026.